Skip to main content Skip to section navigation Skip to footer
ProMIS Neurosciences, Inc.
  • Home
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Clinical Advisory Board
  • Our Science
  • Product Pipeline
    • Overview
    • PMN310 | Amyloid-Beta
    • PMN267 | TDP-43
    • PMN442 | Alpha-Synuclein
    • Vaccines
    • Posters & Publications
  • Clinical Trials
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Results
    • Stock Data
    • SEDAR
    • SEC Filings
    • Governance
  • Contact

Podcasts

News & Media

News & Media

  • Press Releases
  • Events
  • In The News
  • Videos
  • Commentary
  • Podcasts

Episode 27 – Using Artificial Intelligence to speed Alzheimer’s studies

Episode 28 – Dr. Josè Luis Molinuevo of the BarcelonaBeta Brain Research Center on his biomarker presentation at AAIC

Episode 29 – Detecting, treating, and preventing Alzheimer’s disease: Dr. Neil Cashman explains

Episode 30 – Dr. Scott Napper on an Alzheimer’s Vaccine

Episode 31 – Audio white paper: Perspective on Aducanumab’s Nov. 6 Advisory Committee

rss_feed RSS
  • arrow_back
  • 1
  • 2
  • 3
Facebook Linkedin Spotify Twitter
©2025 ProMIS Neurosciences, Inc. All Rights Reserved.
Disclaimer Sitemap Cookie Policy Privacy Policy